The impact of hypertension on left ventricular (LV) and vascular structure and the relation of left ventricular hypertrophy (LVH) with vascular changes in untreated essential hypertensives has not been fully explored. This study investigated the prevalence of structural abnormalities of LV and carotid arteries and their determinants in a large population of untreated, uncomplicated essential hypertensive patients. The Assessment of Prognostic Risk Observational Survey was a multicentre (44 centres) prospective study including 1142 untreated hypertensives classified as low or medium cardiovascular risk on the basis of the routine diagnostic work-up recommended by the 1999 World Health Organization/International Society of Hypertension guidelines. All patients underwent ultrasound examinations of the heart and carotid arteries. LVH and carotid structural changes were diagnosed when: (1) LV mass index exceeded 125 g/m 2 in men and 110 g/m 2 in women; (2) there was at least one plaque (focal thickening41.3 mm) in any segment of either carotid artery or a diffuse common carotid intimamedia thickness (IMT) (average of IMTX0.8 mm) was present. Overall, 1074 patients (504 women, mean age 48.1711.4 years) completed the study with ultrasonographic examinations of good technical quality. The prevalences of LVH and LV concentric remodelling in the total population were 26.8 and 10.7%, respectively. Eccentric hypertrophy was more prevalent than concentric hypertrophy (15.2 vs 11.6%). One or more carotid plaques or thickening were present in 27.4% of the patients. A stepwise increase in IM thickness occurred from the lowest values in patients with normal cardiac mass and geometry (0.68 mm) to intermediate in those with LV remodelling (0.76 mm) and eccentric LVH (0.81 mm) and to the highest level in patients with concentric LVH (0.87 mm). Patients with LV concentric remodelling and concentric LVH had a significantly greater relative carotid wall thickness than those with normal geometry and eccentric LVH (0.25 and 0.26 vs 0.18 and 0.19, respectively, Po0.01). According to a multivariate analysis age, blood glucose, systolic BP and pulse pressure were the main independent predictors of LVH, while age, systolic BP and total cholesterol were the variables with the greatest impact on IM thickening. To conclude, this study shows that: (1) altered patterns of LV structure and geometry and carotid structural changes occur in a large fraction of patients with untreated essential hypertension; (2) there is a significant association between carotid wall thickening and LVH; (3) the probability of LVH or carotid thickening is significantly greater in elderly, in patients with higher systolic BP and in patients with associated metabolic risk factors.
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Introduction
The Assessment of Prognostic Risk Observational Survey (APROS) study 1 has recently shown that the routine laboratory examinations recommended by the 1999 WHO/ISH Guidelines 2 for hypertensive patients underestimate their total cardiovascular risk. This is because in more than 50% of a large number of untreated hypertensive patients classified as being at low or medium risk by medical history, physical examination, routine blood chemistry, urinalysis and an electrocardiogram addition of cardiac and carotid ultrasonography showed left ventricular hypertrophy (LVH) and/or carotid artery wall thickening or plaques, indicating target organ damage (TOD) of adverse prognostic significance, [3] [4] [5] [6] and thus leading to reclassification of these patients as high-risk individuals. This is of major clinical relevance because blood pressure (BP) threshold for treatment, BP target for treatment and concomitant treatment of risk factors other than BP elevation, all depend on hypertensive patients being classified as high or very high rather than at low or medium global cardiovascular risk. 7 We report here the results of further analyses of the APROS data aimed at determining the prevalence of the above-mentioned cardiac and vascular alterations in relation to patient's gender, age, BP level and other cardiovascular risk factors. We thought this would provide useful information on the greater or lesser chance additional examinations have to upgrade a patient's total cardiovascular risk, in relation to common demographic, haemodynamic and metabolic hypertensive phenotypes, thus providing useful suggestions about additional ultrasonographic examinations are more stringently required.
Methods

Study population and design
The APROS study was a prospective observational survey carried out in 44 hospital outpatient hypertension centres in Italy. Patients were considered for preliminary inclusion if: (1) they had never been treated and (2) their BP values were between 90 and 109 mmHg diastolic or 140-179 mmHg systolic at two consecutive visits. Patients with secondary hypertension, presence of cardiovascular disease, diabetes, liver cirrhosis, chronic lung disease and renal disease, were excluded. Those who met these criteria underwent collection of a medical history, a physical examination, office BP measurements, routine blood chemistry, urinalysis, and an electrocardiogram. These diagnostic procedures were used to stratify their total risk of cardiovascular diseases according to 1999 WHO/ISH guidelines criteria. 2 Subjects classified as being at low or medium risk were included in the final part of the study and subjected to an echocardiogram and an ultrasonographic examination of the carotid arteries (see below). The study was approved by the Ethics Committees of each participating centre. Patients gave their written consent after explanation of the nature and purpose of the study.
Blood pressure measurement
Sitting BP was measured in the outpatient clinic by a physician, using a mercury sphygmomanometer, as detailed in Cuspidi et al. 1 The averages of three SBP and DBP consecutive values were used as reference office values.
Echocardiography
Technical details were given in the original APROS study. 1 In brief, M-mode,two-dimensional and Doppler echocardiographic examinations were performed using commercially available instruments. Left ventricular mass (LVM) was estimated from end-diastolic left ventricular internal diameter (LVIDd), interventricular septum (IVS) and posterior wall thickness (PWT) by Devereux's formula 8 
Carotid ultrasonography
Technical details were given in the original APROS study. 1 In brief, plaques were sought in the near (anterior) and far (posterior) walls of the entire extracranial carotid tree based on the presence of a focal wall thickening 41.3 mm. 10 Diffuse intimamedia (IM) thickening was measured in the posterior wall of both common carotids (5,10 and 20 mm caudally to the bifurcation) and diagnosed when there was a diffuse common carotid thickening defined as an average IMTX0.8 mm.
11
In each participating centre, a single experienced physician was responsible for performing both the echocardiographic and carotid ultrasonographic examinations. Detailed written instructions were given to ensure correct examinations. A quality assessment on one preliminary test scan and two study scans from each centre was performed by a core laboratory at the beginning and the end of the study.
Statistical analysis
Statistical analysis was performed by the SAS System (version 6.12; SAS Institute Inc. Cary, NC, USA). Data are reported as means 7s.d. or percentages. Means were compared by the Student's t-test for independent samples. Analysis of categorical data was carried out by the w 2 test or Fisher's exact test when appropriate. The probability of LVH or carotid IM thickening was assessed by calculating odds ratios and their 95% confidence limits, separately for demographic (age and gender) and clinical variables such as body mass index, SBP, DBP, pulse pressure (PP), heart rate, duration of hypertension, blood glucose, serum creatinine, and cholesterol concentrations, and smoking. A logistic multivariate analysis (backward procedure) was performed to investigate the independent and relative importance of these variables for LVH or carotid IM thickening. A two-tailed Po0.05 was considered as statistically significant.
Results
The APROS study began in July 2000. Overall, 8052 consecutive patients were screened up to December of the same year. Of these, 6019 were excluded because they were receiving antihypertensive drugs.
Among the 2483 untreated patients, 1341 were excluded: mostly because they (1) were classified as being at high or very high risk by medical history or routine diagnostic examination (n ¼ 850), (2) had secondary hypertension (n ¼ 91), and (3) were unwilling to participate (n ¼ 351). Thus 1074 patients fulfilled final inclusion criteria.
Patient characteristics
These have been given in Tables 1 and 2 of the original APROS study. 1 A total of 570 patients were males and 504 female subjects; mean age was 48711 years. Based on the classification of the BP levels provided by the 1999 WHO/ISH guidelines, 2 60.9% of the patients had grade 1 and 30.1% grade 2 hypertension. In all, 35.5% of the patients were overweight (body mass index 427.8 kg/m 2 in men and 27.3 kg/m 2 in women), 22.7% were smokers, 17.9% had hypercholesterolaemia (total serum cholesterolX6.5 mmol/l) and 9.9% had a family history of premature cardiovascular disease.
Echocardiographic and ultrasonographic carotid data
Out of 1074 patients, 288 were found to have an LVMI4125 g/m 2 in male and 110 g/m 2 in female .01) and in older (465 years) than younger individuals; whereas a similar prevalence was found in both genders. In the overall population, eccentric hypertrophy was significantly more frequent than concentric hypertrophy (15.2 vs 11.6%, Po0.01), and a noticeable additional group of patients showed concentric remodelling (10.7%). The clinical and ultrasonographic characteristics related to the different LV geometric patterns are shown in Tables 1 and 2 .
Diffuse thickening of the common carotid artery (IMTX0.8 mm) was present in 137 patients (12.8%). One or more carotid plaques or carotid thickening were found in 294 patients (27.2%), with a greater prevalence in grade 2 than in grade 1 hypertension (29.8 vs 25.8%, Po0.05).
LV mass or geometry vs carotid structure
In the 1074 hypertensives there was a positive correlation between LVMI and carotid IMT (r ¼ 0.34, Po0.0001). This association remained significant after controlling for SBP and PP in a multiple regression analysis. As shown in Figure 1 , a stepwise increase in carotid IMT occurred from patients with normal LV mass and geometry to patients with concentric remodelling, eccentric hypertrophy (Po0.01 for both vs normal geometry) and concentric LVH (Po0.01 vs normal geometry and concentric remodelling). This trend remained statistical significant after we had controlled for age, systolic BP and PP. Patients with concentric remodelling and concentric hypertrophy showed a greater carotid relative wall thickness than those with normal LV geometry and eccentric LVH (Po0.01). The prevalence of carotid wall alterations was greater in patients with than in those without LVH (32.9 vs 24.7%, Po0.01).
Factors associated to LVH and carotid IM thickening
LVMI showed a moderate but significant positive correlation with SBP (r ¼ 0.21, Po0.0001), DBP (r ¼ 0.11, Po0.001), and PP (r ¼ 0.16, Po0.0001), whereas carotid IMT showed a positive correlation with SBP (r ¼ 0.25, Po0.0001) and PP (r ¼ 0.22, Po0.001), but not with DBP (r ¼ 0.08, P ¼ NS).
In multivariate logistic regression analysis, LVH was correlated with age over 65 years (odds ratio 3.27, confidence interval (CI) 95% 1.89-5.64), blood glucose over 6.1 mmol/l (odds ratio 3.00, CI 1.79-5.01), SBP4150 mmHg (odds ratio 2.57, CI 1.47-4.49) and PP460 mmHg (odds ratio 1.49, CI 1.08-2.01). Carotid IM thickening was associated with an age4 65 years (odds ratio 5.09, CI 2.51-10.30), SBP4 150 mmHg (odds ratio 2.07, CI 1.13-3.79), total cholesterol46.5 mmol/l (odds ratio 1.85, CI 1.12-3.05). Nonetheless, it has to be remarked that either LV concentric remodelling, LVH or carotid wall alterations were found in 82 subjects (7.6%) without any additional risk factors at routine examinations, and therefore TOD can apparently occur independently of risk factors other than elevated BP.
Discussion
The APROS study 1 has shown that untreated hypertensive patients classified as being at low or medium cardiovascular risk by the routine examinations recommended by the 1999 WHO/ISH Guidelines, 2 frequently show ultrasonographic LVH and/ or carotid artery wall thickening or plaques leading to their reclassification in the high-risk category. This has important clinical implications because in this category BP threshold and timing for initiation of treatment, and the need for additional therapeutic interventions against risk factors other than the BP elevation (eg antiplatelet and lipid-lowering drugs) are different from those required in the lower risk categories. 7 The further analyses of the APROS data performed in this study provide a number of additional findings, however. First, although not showing frank LVH a noticeable proportion of patients, apparently at low or medium risk, had echocardiographic evidence of concentric LV remodelling. This may not have immediate implications for reclassification of the patient's risk, because such concentric remodelling has a much less-pronounced impact on the incidence of cardiovascular events than LVH. 12 It means, however, that cardiac structure is affected by hypertension more commonly than it can be inferred from evidence derived from LVH only. This is in line with the evidence that in animal models myocyte volume increases shortly after an increase in LV afterload, 13, 14 and that in normotensive offsprings of hypertensive parents LVM is already slightly but significantly increased. 15 Second, in the patients of the APROS study, there was a positive relationship between LVMI and carotid IMT values. Furthermore , patients with alterations in LVM and geometry had a greater average carotid IMT than patients with normal LVM and geometry. Finally, carotid IMT showed its greatest average value in patients with concentric LVH, that is, when the LV mass was maximally increased. This confirms previous findings that the alterations in cardiac structure induced by hypertension tend to proceed 'pari passu' with analogous alterations in the arterial wall structure, presumably because cardiac and vascular tissues respond in a manner similar to the mechanical and neurohormonal factors operating in hypertension. 16, 17 Finally, a positive association between LVH and carotid IM thickening was reported by de Simone et al 18 in 2375 normotensive and hypertensive elderly. Nevertheless, it should be emphasized that, although statistically significant, the correlation coefficients between LVMI and carotid IMT were rather low, which means that in several patients cardiac structural alterations were not accompained by carotid ones alterations and vice versa. The practical implication of this selective effect (the mechanisms of which are unknown) is that both ultrasonographic examinations are necessary because the state of one structure cannot be precisely inferred from examining the other. Third, the present study provides information on demographic and clinical characteristics helping to evaluate the probability that hypertensive patients with low or medium cardiovascular risk on routine examinations will have TOD.
The logistic model we employed showed that age and systolic BP, in ranking order, are the most important predictors of the existence of either LVH and carotid wall thickening, a third less important factor being for LVH PP and for carotid-thickening serum cholesterol. This emphasizes the importance that haemodynamic and metabolic factors 19 have in the genesis of the cardiac and vascular alterations accompanying hypertension, the vascular alterations being more than that of cardiac ones that are also influenced by metabolic factors. 20, 21 It further emphasizes that in aged patients as well as in patients with greater elevations in systolic BP and/ or more evident lipid abnormalities ultrasonographic examination of cardiac and vascular structure (in addition to the routine work-up) might be particularly appropriate because of the greater probability of an upgrading of the patient's risk.
The APROS study has a number of qualifying features but also some limitations. Qualifying features are that the APROS study: (1) included a large number of patients on a nationwide multicentre basis, (2) investigated untreated individuals to avoid the confounding effect of antihypertensive drugs on cardiac and vascular structures and (3) standardized the ultrasonographic examination and criteria. The main limitation is that, in order to give the data practical clinical applicability, the study avoided a central blind reading of ultrasonographic examinations. However, testing of a sample of scans for all participating centres by the core laboratory indicated a reliable technical performance. Furthermore, because our sample was selected from a population referred to specialized-hospital-based hypertension clinics, our results may not be representative of hypertensive patients managed in the primary care setting. Indeed, in a population study such as PAMELA 22 the number of untreated hypertensive patients with LVH or LV remodelling was lower than in the present study, despite less conservative criteria. Therefore, our data apply to hypertensives referred to hospital outpatient clinics, in which a wider use of ultrasonographic examinations may be appropriate.
